Ramucirumab plus paclitaxel as a second-line treatment in HER2-positive gastric cancer: subgroup analysis of a nationwide, real-world study in Korea (KCSG-ST19-16)
Titel:
Ramucirumab plus paclitaxel as a second-line treatment in HER2-positive gastric cancer: subgroup analysis of a nationwide, real-world study in Korea (KCSG-ST19-16)
Auteur:
Kim, Bum Jun Jee, Hee-Jung Rha, Sun Young Han, Hye Sook Ryu, Min-Hee Park, Se Hoon Kim, Jong Gwang Bae, Woo Kyun Lee, Keun-Wook Oh, Do-Youn Byun, Ji-Hye Kim, Dong Sook Suh, Young Ju An, Hyonggin Zang, Dae Young